Nonanal, 2-(phenylmethylene)-
Common Name: |
Nonanal, 2-(phenylmethylene)- |
IUPAC Name: |
2-benzylidenenonanal |
Molecular Formula: |
C16H22O |
SMILES: |
CCCCCCCC(=CC1=CC=CC=C1)C=O |
Inchi: |
1S/C16H22O/c1-2-3-4-5-7-12-16(14-17)13-15-10-8-6-9-11-15/h6,8-11,13-14H,2-5,7,12H2,1H3 |
Inchi Key: |
VXDUTTLHVAAEFQ-UHFFFAOYSA-N |
Cas No: |
20175-19-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
230.35 |
Mass (g/mol) |
230.167 |
Molar Refractivity |
75.19 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
8 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
349.00 to 351.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000044 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.44 |
LogP |
4.629 |
iLOGP |
3.09 |
XLOGP3 |
5.32 |
WLOGP |
4.52 |
MLOGP |
3.93 |
ESOL Log S |
-4.35 |
ESOL Solubility (mg/ml) |
0.01 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.43 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-5.26 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.93 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.89 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.95 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |